FDA新冠肺炎公共卫生事件期间药物临床试验执行指南

2020-09-09 美国食品和药品监督管理局 FDA

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergen

中文标题:

FDA新冠肺炎公共卫生事件期间药物临床试验执行指南

英文标题:

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency

发布日期:

2020-09-09

简要介绍:

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency

Docket Number:
FDA-2020-D-1106
Issued by:
Center for Biologics Evaluation and Research
Center for Devices and Radiological Health
Center for Drug Evaluation and Research
Office of the Commissioner, Office of Clinical Policy and Programs, Office of Clinical Policy, Office of Good Clinical Practice

Updated September 21, 2020

FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support response efforts to this pandemic.

FDA is issuing this guidance to provide general considerations to assist sponsors in assuring the safety of trial participants, maintaining compliance with good clinical practice (GCP), and minimizing risks to trial integrity for the duration of the COVID-19 public health emergency. The appendix to this guidance further explains those general considerations by providing answers to questions that the Agency has received about conducting clinical trials during the COVID-19 public health emergency.

相关资料下载:
[AttachmentFileName(sort=1, fileName=66.pdf)] GetToolGuiderByIdResponse(projectId=1, id=aa67b1c0019e78fc, title=FDA新冠肺炎公共卫生事件期间药物临床试验执行指南, enTitle=FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency, guiderFrom=FDA, authorId=0, author=, summary=FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergen, cover=, journalId=0, articlesId=null, associationId=486, associationName=美国食品和药品监督管理局, associationIntro=美国食品和药品监督管理局是美国公共卫生及服务部的一个代理商,其由委员会办公室和4个监督核心功能理事机构组成。, copyright=0, guiderPublishedTime=Wed Sep 09 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<h1 class="text-center content-title" style="color: #333333;">FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Public Health Emergency</h1> <div class="inset-column" style="color: #333333;"> <dl class="lcds-description-list--grid"> <dt class="cell-1_1">Docket Number:</dt> <dd class="cell-2_1"><a style="color: #001871;" href="https://www.regulations.gov/docket?D=FDA-2020-D-1106">FDA-2020-D-1106</a></dd> <dt class="cell-1_2">Issued by:</dt> <dd class="cell-2_2"> <div class="field field--name-field-issuing-office-taxonomy field--type-entity-reference field--label-above"> <div class="field--items"> <div class="field--item">Center for Biologics Evaluation and Research</div> <div class="field--item">Center for Devices and Radiological Health</div> <div class="field--item">Center for Drug Evaluation and Research</div> <div class="field--item">Office of the Commissioner, Office of Clinical Policy and Programs, Office of Clinical Policy, Office of Good Clinical Practice</div> </div> </div> </dd> </dl> </div> <p style="color: #333333;">Updated September 21, 2020</p> <p style="color: #333333;">FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. FDA is committed to providing timely guidance to support response efforts to this pandemic.</p> <p style="color: #333333;">FDA is issuing this guidance to provide general considerations to assist sponsors in assuring the safety of trial participants, maintaining compliance with good clinical practice (GCP), and minimizing risks to trial integrity for the duration of the COVID-19 public health emergency. The appendix to this guidance further explains those general considerations by providing answers to questions that the Agency has received about conducting clinical trials during the COVID-19 public health emergency.</p>, tagList=[TagDto(tagId=109, tagName=临床试验)], categoryList=[CategoryDto(categoryId=67, categoryName=研究设计与统计, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=248, categoryName=真实世界研究, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2445, appHits=33, showAppHits=0, pcHits=429, showPcHits=2412, likes=0, shares=0, comments=0, approvalStatus=1, publishedTime=Sat Sep 26 13:25:45 CST 2020, publishedTimeString=2020-09-09, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Sat Sep 26 13:25:39 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Wed Jan 03 19:33:49 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])
66.pdf
下载请点击:
评论区 (0)
#插入话题